MAPD: a probe design suite for multiplex ligation-dependent probe amplification assays
© Zhi et al; licensee BioMed Central Ltd. 2010
Received: 2 March 2010
Accepted: 21 May 2010
Published: 21 May 2010
Multiplex ligation-dependent probe amplification (MLPA) was originally described as an efficient and reliable technique for gene dosage or DNA copy number variation (CNV) analysis. Due to its low cost, reliability, sensitivity, and relative simplicity, MLPA has rapidly gained acceptance in research and diagnostic laboratories, and fills the gap between genome-wide analysis and single gene analysis. A number of new applications have been developed shortly after the introduction of MLPA, including methylation-specific MLPA (MS-MLPA), the use of MLPA in SNP genotyping, copy number analysis in segmentally duplicated regions, etc. However, probe design is time consuming and error prone. Recently software has been developed to help human genomic MLPA probe selection and optimization. For other genomes and MS-MLPA, probe design remains a challenge.
This paper describes a number of new features added to the previous H-MAPD software, which include: 1) probe selection for MS-MLPA; 2) support of mouse and rat genomes; 3) a set of new stuffer sequences. In addition, a physical-chemical property verification tool was implemented to verify user defined probes.
MAPD is a web-based tool which is freely available to non-commercial users. The previous H-MAPD software has been used by about 200 users from more than 30 countries. With the new features, the author hopes MAPD will bring more convenience to the MLPA community.
Like the original software , MAPD supports both electrophoresis-based and bead-coupled MLPA platforms. The software accepts one or more DNA sequences in FASTA format. Users should specify the genome (human, mouse, rat) to be analyzed. Users will also specify the desired protocol (electrophoresis-based or bead-coupled) and other experiment parameters (See Additional file 1: MAPD input page).
For MS-MLPA (See Additional file 3: Diagram of MS-MLPA), the probe screening inherits all criteria in genomic MLPA probe design, with an additional restriction enzyme filtering process (orange panel in Figure 1) . Firstly, one and only one methylation-sensitive restriction site should be present in the LHS (left hybridizing sequence) and RHS (right hybridizing sequence), otherwise it will be hard to distinguish which site is digested. Secondly, the union of stuffer/tag/primer sequences to the hybridizing sequences may introduce new recognition sites for the methylation-sensitive restriction enzyme being used. Some methylation-sensitive restriction enzymes also digest single-stranded DNA although at a much lower rate. However for methylation frequency study, this might cause extra error to the result. Therefore, LPO (left probe oligo) and RPO (right probe oligo) should not contain extra recognition sites. Thirdly, at least 4 nt on either side of the restriction site should still hybridize to the target sequence, because the enzyme may be less efficient if the restriction site is too close to the end of the double-stranded region of the probe-target hybrid . Lastly, in MS-MLPA, a mutation or SNP within the recognition site of the restriction enzyme could influence the digestion and might yield false results. Therefore, probes containing SNP(s) within the restriction site should also be dropped.
A link will be sent via email to the user upon completion of the analysis. The result page displays all probe sets passing genomic MLPA probe design criteria sorted by scores (See Additional file 4: MAPD result page). A MS-MLPA filter is incorporated in the result page, and can be enabled by clicking the 'Enable MS-MLPA Filter' link. The restriction enzyme recognition site and enzyme name will be displayed for probe sets that pass the restriction enzyme test criteria (See Additional file 5: MS-MLPA filter). The methylation-sensitive restriction enzymes used by MAPD are type II enzymes that cleave DNA within their recognition sequences. In addition, the recognition sequences must not contain multiple CpG dinucleutides (See Additional file 6: Methylation-sensitive restriction enzymes).
The stuffer sequences based on Lambda phage in the original software was suitable for human genomic MLPA only. With the software expanded to MS-MLPA and other genomes, new stuffer sequences need to be designed with the consideration of multiple genomes and restriction enzyme recognition sites. A set of new stuffer sequences has been created based on phage JS98, KVP40, N4, Phi1, T5 (See Additional file 7: Stuffer sequences). All stuffer sequences have been verified to meet following criteria: 1) The union of stuffer sequence and default PCR primer (used by the commercial MRC-Holland MLPA kits) should be free of secondary structures; 2) The union of stuffer sequence and default PCR primer must not have significant homolog to any of the target genomes (human, mouse, rat); 3) The union of stuffer sequence and default PCR primer must not contain restriction sites for any of the methylation-sensitive restriction enzymes used by MAPD; 4) No interactions should occur between different (stuffer sequence + default PCR prime) union sequences.
Physical-chemical property verification tool
MLPA has been successfully applied in SNP genotyping, copy number analysis in segmentally duplicated regions [2, 5]. Both applications put the variation at the 3' end of the LPO. The choices of possible probes are limited, and manual probe selection is usually sufficient for these applications. The uniqueness and variation test that applies to genomic MLPA probe design doesn't apply in this situation. However, physical-chemical property test can still be useful by estimating the secondary structure and melting temperature of probes, and therefore gives an idea if the probes are likely to succeed. The physical-chemical property verification tool offers the convenience for multiple probe verification (See Additional file 8: Physical-chemical property verification tool).
Most MLPA labs use commercial probes from MRC-Holland, or design own probes according to the recommendations of MRC- Holland synthetic probe design protocol http://www.mlpa.com. MAPD mostly follows MRC- Holland probe design guidelines, with a major difference in Tm calculation. MRC-Holland recommends RAW program to determine Tm, while MAPD uses UNAFold. A brief comparison of Tm calculated by RAW and UNAFold is available at http://bioinform.arcan.stonybrook.edu/mlpa2/help_Tm.html. Users are recommended to verify MAPD results with RAW. MAPD provides a rich set of stuffer sequences that have been verified not to interfere with MLPA. With future release of new assemblies of supported genomes, stuffer sequences should be verified using new assemblies.
Availability and requirements
multiplex ligation-dependent probe amplification
copy number variation
University of California at Santa Cruz
single nucleotide polymorphism
left probe oligo
right probe oligo
left hybridizing sequence
right hybridizing sequence
This work is supported by NIH NHGRI grant R03HG005121 and the Office of Scientific Affairs, School of Medicine, Stony Brook University.
- Zhi J, Hatchwell E: Human MLPA Probe Design (H-MAPD): a probe design tool for both electrophoresis-based and bead-coupled human multiplex ligation-dependent probe amplification assays. BMC Genomics. 2008, 9: 407-10.1186/1471-2164-9-407.PubMed CentralPubMedView ArticleGoogle Scholar
- Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002, 30 (12): e57-10.1093/nar/gnf056.PubMed CentralPubMedView ArticleGoogle Scholar
- Nygren AO, Ameziane N, Duarte HM, Vijzelaar RN, Waisfisz Q, Hess CJ, Schouten JP, Errami A: Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 2005, 33 (14): e128-10.1093/nar/gni127.PubMed CentralPubMedView ArticleGoogle Scholar
- Cleavage Efficiency Close to the Termini of PCR Fragments. [http://www.fermentas.com/techinfo/re/restrdigpcrii.htm]
- Kozlowski P, Bissler J, Pei Y, Kwiatkowski DJ: Analysis of PKD1 for genomic deletion by multiplex ligation-dependent probe assay: absence of hot spots. Genomics. 2008, 91 (2): 203-208. 10.1016/j.ygeno.2007.10.003.PubMed CentralPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.